EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey-Reference-Cited by-全球学者库

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

Published:2015-03 Issue:3 Volume:10 Page:438-445
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yatabe Yasushi,Kerr Keith M.,Utomo Ahmad,Rajadurai Pathmanathan,Tran Van Khanh,Du Xiang,Chou Teh-Ying,Enriquez Ma. Luisa D.,Lee Geon Kook,Iqbal Jabed,Shuangshoti Shanop,Chung Jin-Haeng,Hagiwara Koichi,Liang Zhiyong,Normanno Nicola,Park Keunchil,Toyooka Shinichi,Tsai Chun-Ming,Waring Paul,Zhang Li,McCormack Rose,Ratcliffe Marianne,Itoh Yohji,Sugeno Masatoshi,Mok Tony

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Mutation incidence and coincidence in non small-cell lung cancer: Meta-analyses by ethnicity and histology (mutMap);Dearden;Ann Oncol,2013

2. Somatic mutations affect key pathways in lung adenocarcinoma;Ding;Nature,2008

3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis;Frontiers in Oncology;2024-01-23

2. Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722;Journal of Clinical Oncology;2024-01-22

3. Dual-energy CT-based radiomics in predicting EGFR mutation status non-invasively in lung adenocarcinoma;Heliyon;2024-01

4. Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion;Advances in Therapy;2023-10-06

5. Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review;Medicine;2023-10-06